Z-2671-2026 Class II Ongoing
FDA device recall Z-2671-2026 was initiated by Masimo Corporation on Feb 20, 2026 and is designated Class II. Reason for recall: Two devices recalled: 1) Electrocardiogram (ECG) electrode assembly ECG feature may incorrectly detect extreme bradycardia, tachycardia and trigger alarms on normal heart rate patients, which may… The recall status is ongoing. Affected quantity: 1,028.
Recall details
- Product Type
- Devices
- Report Date
- Jul 8, 2026
- Initiation Date
- Feb 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,028
Product description
Reason for recall
Distribution pattern
Worldwide - US Nationwide distribution in the states of OK, CA , MD , MA , NY , UT , NC , TN , MN , TX , OH , PA , VA and the countries of Italy, Latvia, Iraq, Saudi Arabia, Germany, Spain, Turkey, France, Australia, Malta, Oman, United Arab Emirates, Martinique, Netherlands, Cyprus, Kuwait, Czech Republic, United Kingdom, Croatia, Switzerland, Belgium, Singapore, Romania, Colombia, Hong Kong, Israel, Finland, Poland, New Zealand, Tunisia, Chile, Algeria, Canada, Denmark, Palestinian Territory, Qatar, Greece, Paraguay.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2671-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026